For research use only; not for diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Please enter valid quantity
Please log in to add favorites.
NULL OR EMPTY CART
Mixed lineage kinase domain-like protein is encoded by the MLKL gene in murine species. This protein plays a critical role in tumor necrosis factor (TNF)-induced necroptosis, a programmed cell death process, via interaction with receptor-interacting protein 3 (RIP3) key signaling molecules in the necroptosis pathway. Inhibitor studies and knockdown of this gene inhibit TNF-induced necrosis. High levels of this protein and RIP3 are associated with inflammatory bowel disease in children.
The AlphaLISA® SureFire® Ultra™ total mouse MLKL assay is a sandwich immunoassay for the quantitative detection of mouse MLKL (phosphorylated and non-phosphorylated) in cellular lysates, using Alpha Technology. This assay is intended to be used for normalization phosphorylation studies.
AlphaLISA SureFire Ultra kits are compatible with:
Alpha SureFire kits can be used for:
|Experimental Type||In vitro|
|Product Brand Name||AlphaLISA SureFire Ultra|
|Shipping Condition||Blue Ice|
|Therapeutic Area||Neuroinflammation, Oncology, Inflammation|
|Unit Size||10,000 Assay Points|
The introduction of enzyme-linked immunosorbent assays (ELISAs) in the early 1970’s offered researchers a non-radiometric immunoassay platform without compromising sensitivity. Over the last 50 years scientists have made huge strides in disease research and drug discovery and a demand for greater ...
Product brochure for the Alpha Technology, a versatile, no wash, homogeneous assay technology that's suitable for a broad range of applications.
Find out about our range of integrated solutions for drug discovery screening in this e-brochure.
Our screening solutions for high-throughput screening, phenotypic screening and data analysis help to streamline drug discovery workflows in labs across the globe. Our portfolio includes automat ...